Faculty
Beverly MK Biller
Professor of Medicine at Harvard Medical School (HMS), USA
Faculty member in the Neuroendocrine & Pituitary Tumor Clinical Center at Massachusetts General Hospital (MGH) in Boston, Massachusetts, USA
Dr. Biller is Program Director of the Clinical Fellowship in Adult Endocrinology and Metabolism at MGH. She also directs the annual HMS & MGH Continuing Medical Education course “Clinical Endocrinology” that welcomes endocrinologists from around the world to Boston every Spring.
Major research interests include the diagnosis and treatment of Cushing’s disease, acromegaly, prolactinomas, and growth hormone deficiency (GHD) in adults. Dr. Biller has published original research in many peer-reviewed journals and has co-authored clinical guidelines regarding Cushing’s disease for the Endocrine and Pituitary Societies, on pituitary adenomas in pregnancy for the European Society of Endocrinology and on adult GHD for the American Association of Clinical Endocrinologists.
Disclosures
Dr. Biller discloses a grant received from Ascendis, consulting/Honoraria from Merck Serono and consulting honoraria from Novo Nordisk.
All relevant financial relationships have been mitigated.
Michael Buchfelder
Chairman of the Department of Neurosurgery, University of Erlangen-Nuremburg, Germany
Previously Professor and Chairman at the Department of Neurosurgery at the University of Gottingen, Germany
Following medical studies at the Ludwig-Maximilians –University in Munich, he received almost all of his neurological training with Professor Rudolf Fahlbusch, with whom he shared a very close long-term cooperation. Prof. Buchfelder enjoys membership of several scientific organisations, such as the German society of Neurosurgery, the German society of skull base surgery, the European Neuroendocrine Association, the US Endocrine Society, as well as the American Association and Congress of Neurological Surgeons. He has a strong dedication and interest in Neuroendocrinology. He served as Congress President of the Annual Meeting of the German Society of Endocrinology in 2007. He is a member of the editorial boards of Central European Neurosurgery, Acta Endocinologica, the journal of the Endocrine Society and as an Editor of Neurosurgical Reviews. He enjoys honorary membership of several National and International scientific organisations and societies.
Prof. Buchfelder’s areas of research include the pathophysiology, diagnosis and treatment of pituitary and hypothalamic tumours and hormonal disturbances associated with cerebral lesions. He is also particularly interested in imaging of pituitary lesions and performed the central reading of MR images within AcroStudy and Seismic.
Disclosures
Prof Buchfelder has lectured for Pfizer and discloses he is currently involved in a study with Crinetics.
All relevant financial relationships have been mitigated.
Prof Stephen Shalet
Professor Shalet is an Honorary Consultant Endocrinologist at the Christie Hospital, Manchester and Emeritus Professor of Endocrinology at the University of Manchester, UK. He completed a BSc in Physiology at London University and qualified in medicine at the Royal London Hospital. Hospital medical training posts in London and Bristol were followed by an appointment as Research Fellow in Endocrinology at the Christie Hospital, Manchester.
Professor Shalet has extensive research interests in the late endocrine effects following treatment of cancer, pituitary disorders and in particular abnormalities of growth hormone secretion He is the author/co-author of over 500 articles and more than 200 of these are related to clinical disorders of the GH-IGF-1 axis and/or therapeutic use of GH therapy in man.
Previous positions and official activities include Chairman of the Strategic Planning Committee of the European Society of Pediatric Endocrinology, Co-Editor of the first edition of the Oxford Textbook of Endocrinology and a member of the Council of the Society for Endocrinology and the SAC in Endocrinology and Diabetes. Professor Shalet has served as President of the Endocrine Section of the Royal Society of Medicine, as a member of the Council of the European Society of Paediatric Endocrinology, was Chairman of the Specialist Training Committee in Diabetes and Endocrinology for the North West Region and as a member of the Clinical Practice Committee of the Society for Endocrinology.
Disclosures
Professor Shalet discloses grants or honoraria received from NovoNordisk, Saizen and Merck. All relevant financial relationships have been mitigated.
Prof Stephanie Baldeweg
Consultant Endocrinologist, Department of Diabetes & Endocrinology, UCLH
Clinical Lead, Department of Diabetes & Endocrinology, UCLH
Honorary Professor, Centre for Obesity & Metabolism, Department of Experimental & Translational Medicine, Division of Medicine, UCL
Professor Stephanie Baldeweg works as a Consultant Physician in Diabetes and Endocrinology at University College London Hospital and as Honorary Professor at the Centre for Obesity and Metabolism, Department of Experimental and Translational Medicine, at University College London. She is Clinical Lead of the Department of Diabetes and Endocrinology at UCLH. She graduated from Humboldt University Berlin in 1990 and was awarded her MD on “Insulin resistance and endothelial function in health and type 2 diabetes” in 2002 in London. She was elected Fellow of the Royal College of Physicians of Ireland and of the Royal College of Physicians in London (FRCP) in 2009.
Professor Baldeweg has held a number of National Roles including Associate Academic Dean, Health Education England and Associate Director for Higher Specialties Training, UCL Partners. She is chair of the Clinical Committee, UK Society for Endocrinology and chair of the Joint Specialty Committee for Endocrinology and Diabetes at the Royal College of Physicians.
Professor Baldeweg is interested in all aspects of diabetes and endocrinology. She has a special clinical and research interest in pituitary disease, traumatic brain injury, menopause, transition, general endocrinology and late effects. Her main academic interest aims to improve patient care through systematic clinical research with a focus on cross-specialty working and comorbidities. She has published widely on endocrinological topics, particularly on pituitary disease and is a member of the British Neurotrauma Group and a co-author on the national guidance for The screening and management of pituitary dysfunction following traumatic brain injury in adults.
Prof Baldeweg is a keen medical educator and regularly lectures at national and international meetings as well as Patient days for UK charities.
Disclosures
Stephanie Baldeweng has no financial / non-financial relationships of conflicts of interest to declare.
